Lehman Financial Resources, Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 161 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lehman Financial Resources, Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,040,000
+22.2%
6,4420.0%0.49%
+13.8%
Q2 2018$851,000
+78.4%
6,4420.0%0.43%
+75.8%
Q1 2018$477,000
+10.7%
6,442
-16.9%
0.24%
+8.9%
Q4 2017$431,000
+49.1%
7,753
+21.3%
0.22%
+52.4%
Q3 2017$289,000
+26.8%
6,392
-6.8%
0.15%
+14.8%
Q2 2017$228,000
+12.3%
6,8610.0%0.13%
+14.3%
Q1 2017$203,000
-14.3%
6,861
+77.7%
0.11%
-18.2%
Q3 2016$237,000
-70.6%
3,861
-90.7%
0.14%
-68.1%
Q1 2016$806,000
-49.4%
41,3110.0%0.43%
-49.9%
Q4 2015$1,593,000
+20.1%
41,3110.0%0.86%
+27.1%
Q3 2015$1,326,000
-14.4%
41,311
-18.9%
0.68%
-10.0%
Q2 2015$1,549,000
+338.8%
50,911
+91.3%
0.75%
+363.0%
Q1 2015$353,000
-1.9%
26,611
+6.8%
0.16%
-8.5%
Q4 2014$360,000
-4.8%
24,911
+39.1%
0.18%
-10.2%
Q3 2014$378,000
-30.6%
17,911
-2.2%
0.20%
-24.2%
Q2 2014$545,000
+23.9%
18,3110.0%0.26%
+14.0%
Q1 2014$440,000
+24.6%
18,311
+5.8%
0.23%
+4.6%
Q4 2013$353,000
-56.8%
17,3110.0%0.22%
-58.4%
Q3 2013$818,000
+3.3%
17,311
-16.9%
0.52%
-2.2%
Q2 2013$792,000
-15.3%
20,832
-17.7%
0.54%
-19.9%
Q1 2013$935,000
+46.1%
25,313
+2.0%
0.67%
+19.0%
Q4 2012$640,00024,8130.56%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,999,453$413,414,60713.31%
Casdin Capital, LLC 1,160,000$159,882,80013.17%
Ikarian Capital, LLC 271,300$37,393,2798.48%
Avoro Capital Advisors LLC 3,650,000$503,079,5007.46%
Evolutionary Tree Capital Management, LLC 36,190$4,988,0686.91%
Finepoint Capital LP 122,757$16,919,5976.46%
Ikarian Capital, LLC 205,400$28,310,2826.42%
Boxer Capital, LLC 775,000$106,8185.25%
Ghost Tree Capital, LLC 125,000$17,229,0005.09%
Logos Global Management LP 220,000$30,322,6004.34%
View complete list of SAREPTA THERAPEUTICS INC shareholders